The S&P 500 climbed 0.6% on Wednesday, while SpaceX stock slumped more than 10% on its first quarterly report since going ...

The Dow and S&P 500 hit new highs while the Nasdaq powered higher again. SpaceX, AMD and Arista led earnings movers late.

Eli Lilly (NYSE:LLY) news as US markets steady near records ahead of July CPI, with the drugmaker's research operations and healthcare stocks in focus.

Wall Street’s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, ...

Eli Lilly (LLY) ended the recent trading session at $1,146.90, demonstrating a -2.73% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the ...

The US stock market opened higher on Wednesday, with the S&P 500, Dow Jones, and Nasdaq extending gains after a record close.

Eli Lilly & Co. closed 2.76% below its 52-week high of $1,249.45, which the company reached on July 7th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated ...

S&P 500 mixed, XLV outperformed, top gainers/losers, plus key news on drug tariffs, GLP-1 ads, and deals—read now.

The major U.S. equities indexes were mixed at midday Thursday, with the Dow Jones Industrial Average down close to 400 points ...

Discover 11 S&P 500 stocks going ex-dividend Aug. 10-17, and why analysts are divided on the impact of Apple’s new AI ...

With a share price of $1,182, Eli Lilly (LLY) is positioned for about 76% potential growth over the next three years in a conservative scenario.